Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.58 |
| ▸ | DPP7 | Q9UHL4 | 14/20 | 0.58 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.54 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL764603 | 0.89 | DPP4 (0.66) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL764705 | 0.89 | DPP4 (0.59) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL8246266 | 0.86 | DPP4 (0.56) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL12284444 | 0.86 | DPP4 (0.56) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL13703651 | 0.83 | DPP4 (0.60) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL12284256 | 0.81 | DPP4 (0.80) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL764573 | 0.81 | DPP4 (0.80) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL764672 | 0.76 | DPP4 (0.72) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL8258837 | 0.76 | DPP4 (0.82) | DPP4DPP7DPP9KCNH2CYP2D6 | |
| SCHEMBL12284523 | 0.76 | DPP4 (0.72) | DPP4DPP7DPP9KCNH2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1921917-B1 | FUSED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | MERCK SHARP & DOHME (US) | 2012-03-21 | — | — | EP | disclosed |
| WO-2007024993-A2 | FUSED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | MERCK & CO., INC. (US) | 2007-03-01 | — | — | WO | disclosed |